Pulmonary Hypertension and Liver Disease: What’s the Link Between Them?

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

Is there an explanation for the association of pulmonary arterial hypertension with intravenous drug use or chronic liver disease? Does the risk of developing PAH increases with IV drug use? impactID.com clears up doubt with this short interview with Dr. Harrison Farber, where some of the potential causes of PAH are discussed, as well as the influence of intravenous drug and chronic liver disease.

Harrison W. Farber, MD, is the director of Pulmonary Hypertension Center Boston University/Boston Medical Center. Learn more about him: http://bit.ly/1Skf7Ni

Read the latest updates on pulmonary hypertension.

Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

 

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

liver disease, PAH, pulmonary arterial hypertension (PAH), Pulmonary hypertension (PH)

Recent Posts


A Conversation With Rare Disease Advocates

Recommended reading